Cargando…

Anti-leucine-rich Glioma-inactivated-1 Encephalitis with Faciobrachial Dystonic Seizures and Behavioral Problems: A Case Report

Anti-Leucine-rich glioma-inactivated-1 encephalitis is a subtype of autoimmune encephalitis characterized by cognitive impairment, faciobrachial dystonic seizures, and behavioural changes. There is no reported case from Nepal. We report a case of a 54-year old male who presented with abnormal body m...

Descripción completa

Detalles Bibliográficos
Autores principales:	Adhikari, Ayush, Subedi, Ram Chandra, Acharya, Subi, Paudei, Raju
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Journal of the Nepal Medical Association 2020
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7580401/ https://www.ncbi.nlm.nih.gov/pubmed/32827010 http://dx.doi.org/10.31729/jnma.5008

Ejemplares similares

Gastaut-Geschwind Syndrome, Faciobrachial Dystonic Seizure, and Autoimmune Limbic Encephalitis
por: Benhamou, Ori-Michael J., et al.
Publicado: (2018)

Hippocampal Functional Dynamics Are Clinically Implicated in Autoimmune Encephalitis With Faciobrachial Dystonic Seizures
por: Nantes, Julia C., et al.
Publicado: (2018)

The importance of early immunotherapy in patients with faciobrachial dystonic seizures
por: Thompson, Julia, et al.
Publicado: (2018)

Faciobrachial Dystonic Seizures as a Sign of Relapse in a Child with LGI-1 Encephalitis
por: Alotaibi, Wajd, et al.
Publicado: (2022)

Rasmussen's Encephalitis with Faciobrachial Dystonic Attacks and Bilateral Hemispheric Involvement
por: Chen, Jian-Hua, et al.
Publicado: (2016)

The importance of recognizing faciobrachial dystonic seizures in rapidly progressive dementias
por: Simabukuro, Mateus Mistieri, et al.
Publicado: (2016)

Rapidly Progressive Cognitive Impairment with Faciobrachial Dystonic Seizures (FBDS) in Anti-LGI1 Encephalitis
por: Yin, Weifang, et al.
Publicado: (2022)

Confusion, Faciobrachial Dystonic Seizures, and Critical Hyponatremia in a Patient with Voltage-Gated Potassium Channel Encephalitis
por: Yaxley, Julian
Publicado: (2017)

Into a Shaking Limbo: Case Report of a Nonneoplastic Limbic Encephalitis with Faciobrachial Dystonic Seizures and Parkinsonism
por: Renga, Vijay
Publicado: (2020)

Basal ganglia T1 hyperintensity in LGI1-autoantibody faciobrachial dystonic seizures
por: Flanagan, Eoin P., et al.
Publicado: (2015)

Faciobrachial dystonic seizures result from fronto–temporo–basalganglial network involvement
por: Iyer, Rajesh Shankar, et al.
Publicado: (2017)

LGI1-negative faciobrachial dystonic-like seizures originating from the insula
por: Patira, Riddhi, et al.
Publicado: (2016)

Striking basal ganglia imaging abnormalities in LGI1 ab faciobrachial dystonic seizures
por: López Chiriboga, A. Sebastian, et al.
Publicado: (2017)

Facio-brachio-crural dystonic episodes and drop attacks due to leucine rich glioma inactivated 1 encephalitis in two elderly Indian women
por: Maramattom, Boby Varkey, et al.
Publicado: (2013)

Leucine-Rich Glioma-Inactivated 1 Encephalitis: Broadening the Sphere
por: Rachdi, Amine, et al.
Publicado: (2019)

Clinical analysis of leucine-rich glioma inactivated-1 protein antibody associated with limbic encephalitis onset with seizures
por: Li, Zhimei, et al.
Publicado: (2016)

Limbic encephalitis associated with leucine-rich glioma-inactivated 1 antibodies
por: Messelmani, Mariem, et al.
Publicado: (2015)

Reversible Bilateral Striatal Hypermetabolism in a Patient with Leucine-Rich Glioma Inactivated-1 Encephalitis
por: Takkar, Aastha, et al.
Publicado: (2016)

Anti-leucine-rich Glioma Inactivated-1 Encephalitis Associated with Essential Thrombocythemia
por: Yuan, Xiaoling, et al.
Publicado: (2020)

Seronegative Autoimmune Basal Ganglia Encephalitis Presenting as Acute Parkinsonism and Refractory Faciobrachial Seizures: A Case Report
por: Giri, Anamika, et al.
Publicado: (2022)

Leucine-rich glioma-inactivated protein 1 antibody encephalitis: A case report
por: Mayasi, Yunis, et al.
Publicado: (2014)

Motor Phenomena Associated With Leucine-Rich Glioma-Inactivated (LGI1) Emi-Encephalitis
por: Giorelli, Maurizio, et al.
Publicado: (2023)

Electroclinical characterization of epileptic seizures in leucine-rich, glioma-inactivated 1-deficient mice
por: Chabrol, Elodie, et al.
Publicado: (2010)

Leucine-rich Glioma-inactivated 1 Encephalitis Followed by Isaacs Syndrome: Alternating Presence of Pathogenic Autoantibodies to Leucine-rich Glioma-inactivated 1 and Contactin-associated Protein-like 2
por: Murayama, Aki, et al.
Publicado: (2022)

Faciobrachial motor seizures: A more apt description?
por: Muthusamy, Subramanian, et al.
Publicado: (2021)

CXCL13 Is A Biomarker Of Anti-Leucine-Rich Glioma-Inactivated Protein 1 Encephalitis Patients
por: Lin, You-ting, et al.
Publicado: (2019)

Residual Fatigue and Cognitive Deficits in Patients After Leucine-Rich Glioma-Inactivated 1 Antibody Encephalitis
por: Binks, Sophie N. M., et al.
Publicado: (2021)

Anti-leucine-rich glioma-inactivated 1 encephalitis: two case reports and a review of the literature
por: Karvigh, Sanaz Ahmadi, et al.
Publicado: (2022)

CXCL13 Is a Biomarker of Anti-Leucine-Rich Glioma-Inactivated Protein 1 Encephalitis Patients [Letter]
por: Wei, Mingyu, et al.
Publicado: (2020)

Telemedicine assessment of long-term cognitive and functional status in anti-leucine-rich, glioma-inactivated 1 encephalitis
por: Sola-Valls, Nuria, et al.
Publicado: (2019)

Clinical Features and Therapeutic Effects of Anti-leucine-rich Glioma Inactivated 1 Encephalitis: A Systematic Review
por: Teng, Yuou, et al.
Publicado: (2022)

Persistent hiccup as one of the initial symptoms of leucine-rich glioma-inactivated-1 encephalitis: a case report
por: Hou, Lan, et al.
Publicado: (2022)

CXCL13 Is a Biomarker of Anti-Leucine-Rich Glioma-Inactivated Protein 1 Encephalitis Patients [Response to Letter]
por: Wang, Sheng-jun, et al.
Publicado: (2020)

Clinical Features and Gut Microbial Alterations in Anti-leucine-rich Glioma-Inactivated 1 Encephalitis—A Pilot Study
por: Ma, Xueying, et al.
Publicado: (2020)

Serial assessment of multimodality imaging in anti-leucine-rich glioma-inactivated 1 antibody encephalitis: A case report
por: Wada, Takafumi, et al.
Publicado: (2022)

CHI3L1 in the CSF is a potential biomarker for anti-leucine-rich glioma inactivated 1 encephalitis
por: Li, Jinyi, et al.
Publicado: (2023)

A case of leucine-rich glioma-inactivated 1 antibody encephalitis with schizophrenia-like symptoms as an initial clinical manifestation
por: Moon, Jiyeon, et al.
Publicado: (2022)

Anti-Leucine-Rich Glioma-Inactivated 1 Limbic Encephalitis with Normal Magnetic Resonance Imaging Detected on Fluordeoxygluose Positron Emission Tomography/Computed Tomography
por: Chandra, Piyush, et al.
Publicado: (2020)

A Psychiatric Side Effect of Levetiracetam Can Mimic a Relapse of Anti-Leucine-Rich Glioma Inactivated 1 Encephalitis
por: Jang, Yoonhyuk, et al.
Publicado: (2018)

Clinical Features and Long-Term Outcomes of Anti-Leucine-Rich Glioma-Inactivated 1 Encephalitis: A Multi-Center Study
por: Qiao, Shan, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_m7ni06sjbd5iudoi1hm82v0ah8